FDA Approves Label Update for Secukinumab in Ankylosing Spondylitis
The U.S. Food and Drug Administration has approved a label update for secukinumab (Cosentyx, Novartis) to include the option for up-titration to a 300 mg dose for adults with active ankylosing spondylitis.
 
Tocilizumab May Help Uveitis in Juvenile Idiopathic Arthritis
Tocilizumab might be a useful adjunctive therapeutic option for children with juvenile idiopathic arthritis-associated uveitis that doesn't respond to TNFi treatment, say researchers recently writing in The Lancet Rheumatology.
 
20 Key Takeaways From the Rheumatology Pregnancy Guidelines
Most women with rheumatic and musculoskeletal diseases will have successful pregnancies with the aid of medical planning, treatment and monitoring. The American College of Rheumatology recently issued treatment guidelines for the management of reproductive health in patients with rheumatic or musculoskeletal disease. Here are takeaways from the guidelines.
 
Visit Rheumatology Network for easy access to new job opportunities in rheumatology. As a service to our readers, we've posted a national "Job Board" in the upper right-hand corner of the site. Suggestions for other content sections? Email the editor at areyes@mmhgroup.com.